Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance - ScienceDirect
Por um escritor misterioso
Descrição
Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance - ScienceDirect
Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement - ScienceDirect
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion - ScienceDirect
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
What drives glycolysis in tumors, and how to stop it
N1-methyladenosine modification in cancer biology: Current status and future perspectives - Computational and Structural Biotechnology Journal
Advances in targeting RNA modifications for anticancer therapy: Trends in Cancer
Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy - ScienceDirect
RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer - ScienceDirect
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells - ScienceDirect
FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis - ScienceDirect
Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy - Computational and Structural Biotechnology Journal
Acetylation in pathogenesis: Revealing emerging mechanisms and therapeutic prospects - ScienceDirect
Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance - ScienceDirect
FTO in cancer: functions, molecular mechanisms, and therapeutic implications: Trends in Cancer